This demonstrates that the model of CLU+ve cells repopulating LGR5+ve CSCs after loss or damage can also be observed in vitro. Therefore, the CLU+ve regenerative stem cell is emerging as a potential therapeutic target for the prevention of chemo- and radiotherapy resistance and tumour relapse. The gene discussed is CLU; the disease is neoplasm.